Cargando…
Atropo‐Enantioselective Oxidation‐Enabled Iridium(III)‐Catalyzed C−H Arylations with Aryl Boronic Esters
Atropo‐enantioselective biaryl coupling through C−H bond functionalization is an emerging technology allowing direct construction of axially chiral molecules. This approach is largely limited to electrophilic coupling partners. We report a highly atropo‐enantioselective C−H arylation of tetralone de...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457206/ https://www.ncbi.nlm.nih.gov/pubmed/34153163 http://dx.doi.org/10.1002/anie.202106403 |
_version_ | 1784571038320820224 |
---|---|
author | Woźniak, Łukasz Cramer, Nicolai |
author_facet | Woźniak, Łukasz Cramer, Nicolai |
author_sort | Woźniak, Łukasz |
collection | PubMed |
description | Atropo‐enantioselective biaryl coupling through C−H bond functionalization is an emerging technology allowing direct construction of axially chiral molecules. This approach is largely limited to electrophilic coupling partners. We report a highly atropo‐enantioselective C−H arylation of tetralone derivatives paired with aryl boronic esters as nucleophilic components. The transformation is catalyzed by chiral cyclopentadienyl (Cp(x)) iridium(III) complexes and enabled by oxidatively enhanced reductive elimination from high‐valent cyclometalated Ir‐species. |
format | Online Article Text |
id | pubmed-8457206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84572062021-09-28 Atropo‐Enantioselective Oxidation‐Enabled Iridium(III)‐Catalyzed C−H Arylations with Aryl Boronic Esters Woźniak, Łukasz Cramer, Nicolai Angew Chem Int Ed Engl Communications Atropo‐enantioselective biaryl coupling through C−H bond functionalization is an emerging technology allowing direct construction of axially chiral molecules. This approach is largely limited to electrophilic coupling partners. We report a highly atropo‐enantioselective C−H arylation of tetralone derivatives paired with aryl boronic esters as nucleophilic components. The transformation is catalyzed by chiral cyclopentadienyl (Cp(x)) iridium(III) complexes and enabled by oxidatively enhanced reductive elimination from high‐valent cyclometalated Ir‐species. John Wiley and Sons Inc. 2021-07-16 2021-08-16 /pmc/articles/PMC8457206/ /pubmed/34153163 http://dx.doi.org/10.1002/anie.202106403 Text en © 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Communications Woźniak, Łukasz Cramer, Nicolai Atropo‐Enantioselective Oxidation‐Enabled Iridium(III)‐Catalyzed C−H Arylations with Aryl Boronic Esters |
title | Atropo‐Enantioselective Oxidation‐Enabled Iridium(III)‐Catalyzed C−H Arylations with Aryl Boronic Esters |
title_full | Atropo‐Enantioselective Oxidation‐Enabled Iridium(III)‐Catalyzed C−H Arylations with Aryl Boronic Esters |
title_fullStr | Atropo‐Enantioselective Oxidation‐Enabled Iridium(III)‐Catalyzed C−H Arylations with Aryl Boronic Esters |
title_full_unstemmed | Atropo‐Enantioselective Oxidation‐Enabled Iridium(III)‐Catalyzed C−H Arylations with Aryl Boronic Esters |
title_short | Atropo‐Enantioselective Oxidation‐Enabled Iridium(III)‐Catalyzed C−H Arylations with Aryl Boronic Esters |
title_sort | atropo‐enantioselective oxidation‐enabled iridium(iii)‐catalyzed c−h arylations with aryl boronic esters |
topic | Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457206/ https://www.ncbi.nlm.nih.gov/pubmed/34153163 http://dx.doi.org/10.1002/anie.202106403 |
work_keys_str_mv | AT wozniakłukasz atropoenantioselectiveoxidationenablediridiumiiicatalyzedcharylationswitharylboronicesters AT cramernicolai atropoenantioselectiveoxidationenablediridiumiiicatalyzedcharylationswitharylboronicesters |